ECMO versus off-pump double lung transplant care
Part of Lungs & breathing clinical trials.
This study compares two ways of supporting the lungs and heart around the time of a double lung transplant: venoarterial ECMO versus an off-pump approach. It may help your team choose the safest support method based on your heart-lung pressures and surgical plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had (or are receiving) a double lung transplant (both lungs).
- Your average pulmonary artery pressure is 35 mmHg or lower.
- Your transplant surgeon thinks either ECMO or off-pump support could be appropriate for you.
- You are not having a single-lung transplant.
- You are not receiving (or planning) a prophylactic—planned-in-advance—ECMO after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special heart-lung support machine (ECMO) for people waiting for a lung transplant whose heart is failing due to high blood pressure in the lungs. The machine helps rest the heart and lungs until transplant surgery.
This study looks at how your lungs respond to exercise after a double lung transplant. It aims to understand normal recovery patterns and may help improve care for other transplant recipients.
This study follows people who are getting a double lung transplant and have specific lung-only (or lung-limited) cancer or other serious lung conditions. It’s an observational registry, meaning it collects real-world information to learn which patients may benefit from transplant and how they do afterward.
This study compares two ways of using a heart-lung machine (ECMO) during lung transplant surgery. The goal is to see if using ECMO only when needed works as well as using it for everyone. This could help reduce risks and improve recovery.
This study looks at using a heart–lung machine (ECMO) to reduce complications and deaths after a lung transplant. It focuses on people getting a lung transplant who have certain types of lung-vessel (pulmonary) pressure problems.
This study compares two different blood thinners (UFH and LMWH) used during heart-lung bypass (ECMO) for double lung transplant patients. The goal is to see which one works better and is safer.
Hear when a new Lung Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.